Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells
Feng-li Hao, Xiao-fang Han, Xiaoli Wang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 181-187
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction
Fuyuko Takata, Shinsuke Nakagawa, Junichi Matsumoto, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 323
Factors influencing the blood-brain barrier permeability
Yibin Zhao, Lin Gan, Li Ren, et al.
Brain Research (2022) Vol. 1788, pp. 147937-147937
Open Access | Times Cited: 124
Aloin Protects Against Blood–Brain Barrier Damage After Traumatic Brain Injury in Mice
Jing Yao, Dianxu Yang, Wei Wang, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 6, pp. 625-638
Open Access | Times Cited: 35
Potential neuroprotective and autophagy-enhancing effects of alogliptin on lithium/pilocarpine-induced seizures in rats: Targeting the AMPK/SIRT1/Nrf2 axis
Sarah S El-Sayed, Shimaa O. Ali, Weam W. Ibrahim
Life Sciences (2024) Vol. 352, pp. 122917-122917
Closed Access | Times Cited: 4
Mechanistic insights toward progress in alogliptin beyond glycemic control: translational perspective
Faraha Ahmed, Syed Sufian Ahmad, Mohammad Mumtaz Alam, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2025) Vol. 14, Iss. 1
Open Access
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's disease
Maanvi, Shilpa Kumari, Rahul Deshmukh
European Journal of Pharmacology (2022) Vol. 939, pp. 175426-175426
Closed Access | Times Cited: 14
Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease
Syed Obaidur Rahman, Madhu Kaundal, Mohd Salman, et al.
European Journal of Pharmacology (2020) Vol. 889, pp. 173522-173522
Closed Access | Times Cited: 22
NDRG2 attenuates ischemia-induced astrocyte necroptosis via the repression of RIPK1
Jie Zhu, Likun Yang, Qiuhong Wang, et al.
Molecular Medicine Reports (2020)
Open Access | Times Cited: 21
Alogliptin inhibits IL-1β-induced inflammatory response in fibroblast-like synoviocytes
Qi Guo, Shun Zhang, Jiuqin Huang, et al.
International Immunopharmacology (2020) Vol. 83, pp. 106372-106372
Closed Access | Times Cited: 17
Post-acute ischemic stroke hyperglycemia aggravates destruction of the blood-brain barrier
Tianqi Xu, Jianhong Yang, Xu Yao, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1344-1350
Open Access | Times Cited: 6
Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron
Eleni Xourgia, Athanasia Papazafiropoulou, Αndreas Μelidonis
World Journal of Diabetes (2019) Vol. 10, Iss. 3, pp. 169-180
Open Access | Times Cited: 17
Neuroprotective Effects of Diabetes Drugs for the Treatment of Neonatal Hypoxia-Ischemia Encephalopathy
Laura Poupon-Bejuit, Eridan Rocha‐Ferreira, Claire Thornton, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 14
The effect and mechanism of combination of total paeony glycosides and total ligustici phenolic acids against focal cerebral ischemia
Junfei Gu, Liang Feng, Jie Song, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Exploring DPP IV inhibitors for Alzheimer’s disease: Bridging diabetes and neurodegeneration
Swagata Pattanaik, Shakti Ketan Prusty, Pratap Kumar Sahu
Brain Research (2024) Vol. 1848, pp. 149342-149342
Closed Access | Times Cited: 1
Inhibition of TIM‐4 protects against cerebral ischaemia‐reperfusion injury
Lifang Zheng, Yongqian Huang, Xinghua Wang, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 2, pp. 1276-1285
Open Access | Times Cited: 7
Sijunzi decoction may decrease apoptosis via stabilization of the extracellular matrix following cerebral ischaemia‑reperfusion in rats
Ping Yang, Ye‐Mei Tian, Wen‐Xiang Deng, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 5
Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke
Ya-Li Guan, Pengfei Li, Yingshuo Liu, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 6
Open Access | Times Cited: 5
Small molecule compound K-7174 attenuates neuropsychiatric manifestations in lupus-prone mice
Yu Fan, Xuan Liu, Jinjin Wu, et al.
Brain Research (2022) Vol. 1801, pp. 148203-148203
Closed Access | Times Cited: 3
Of mice and men: incretin actions in the central nervous system
Olivia M. Farr, Eleni Pilitsi, Christos S. Mantzoros
Metabolism (2019) Vol. 98, pp. 121-135
Closed Access | Times Cited: 3
An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes
Jingbo Hu, Chun-Lin Yang, Hongbo Wang, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 14, pp. 1679-1687
Closed Access | Times Cited: 3
Bradykinin Potentiating Factor from Egyptian Honey Bee Venom Fraction: A Potential Therapeutic Agent for Type 1 Diabetes
Tito N. Habib, Soheir A El Raheem, Abu-Amra El-Sabry, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Bradykinin Potentiating Factor from Egyptian Honey Bee Venom Fraction: A Potential Therapeutic Agent for Type 1 Diabetes
Tito N. Habib, Soheir A El Raheem, Abu-Amra El-Sabry, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
In-vivo thrombolytic efficacy of RGD modified protein-polymer conjugated urokinase nanogels
Xia Liu, Lingli Jin, Lingling Zhao, et al.
Polymer Testing (2021) Vol. 104, pp. 107392-107392
Open Access | Times Cited: 3
Effects of Systematic Diet Education Combined with Multidisciplinary Nursing on Nutritional Status and Calcium and Phosphorus Metabolism in Patients with Diabetic Kidney Disease in Uremic Phase after Treatment with Alogliptin
Ning Guo, Na Li, Yan Zhao, et al.
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 2
Trelagliptin Mitigates Macrophage Infiltration by Preventing the Breakdown of the Blood–Brain Barrier in the Brain of Middle Cerebral Artery Occlusion Mice
Li’e Zang, Bo Yang, Mingyuan Zhang, et al.
Chemical Research in Toxicology (2021) Vol. 34, Iss. 4, pp. 1016-1023
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top